
Hugo Akabane MD
Hematology/Oncology
Program Director Leukemia & Bone Marrow Transplant
Join to view full profile
4805 NE Glisan StSte 11NPortland, OR 97213
Phone+1 503-215-1350
Dr. Akabane is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)/FresnoFellowship, Hematology and Medical Oncology, 2017 - 2020
MetroWest Medical CenterResidency, Internal Medicine, 2017
Paulista School of MedicineClass of 2002
Certifications & Licensure
FL State Medical License 2025 - 2027
OR State Medical License 2023 - 2027
OH State Medical License 2023 - 2025
LA State Medical License 2020 - 2024
CA State Medical License 2017 - 2022
MA State Medical License 2014 - 2017
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Detection of MRD positivity as an indicator of CNS relapse in AML and therapeutic approach.Sumasri Chennapragada, Vishal Devarkonda, Hugo Akabane
BMJ Case Reports. 2025-04-30 - 1 citationsAdalimumab-associated Philadelphia chromosome positive acute lymphoblastic leukaemia in a patient with Crohn's disease.Vishal Devarkonda, Shravya Balmuri, Maria Antonia Costa Cruz Akabane, Hugo Akabane
BMJ Case Reports. 2023-10-24 - 1 citationsTransforming Acute Myeloid Leukemia Treatment Through Next-Generation Sequencing: A Single-Center Experience.Vishal Devarkonda, Hugo Akabane
Cureus. 2023-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









